Synergistic Dermatological Compositions and Systems for Enhanced Skin Health

The present inventive concept integrates the novel bacterial extract of the original patent with distinct technologies such as AI, IoT, blockchain, and new materials to create a more powerful system for treating sensitive skin and cutaneous neurogenic inflammation.

The original patent disclosed a novel bacterial extract for treating sensitive skin, but it had limitations in terms of personalized treatment, real-time monitoring, and efficacy tracking. The present inventive concept addresses these limitations by combining the bacterial extract with advanced technologies to provide a more comprehensive and effective solution.

The inventive concept comprises a range of synergistic combinations, including an AI-powered skin analysis module for personalized treatment, a blockchain-based tracking system for monitoring treatment efficacy, an IoT-enabled skin sensor for real-time skin condition monitoring, and novel material compositions for wound healing and transdermal delivery. These combinations enhance the delivery, efficacy, and user experience of the bacterial extract, providing a more powerful system for treating sensitive skin and cutaneous neurogenic inflammation.

The new claims introduce novel and non-obvious combinations of the bacterial extract with distinct technologies, providing a synergistic effect that is not anticipated by the original patent or the individual technologies alone. The inventive concept's novelty lies in the integration of these technologies to create a more comprehensive and effective solution for treating sensitive skin and cutaneous neurogenic inflammation.

Alternative embodiments of the inventive concept could include the use of other AI algorithms, IoT sensors, or blockchain platforms. Variations could also include the integration of additional technologies, such as augmented reality or 5G connectivity, to further enhance the user experience and treatment outcomes.

The inventive concept has significant commercial potential in the dermatological and cosmetic industries, with applications in personalized skincare, wound healing, and skin condition monitoring. The target market includes consumers with sensitive skin, as well as healthcare professionals and researchers seeking more effective and efficient treatments for cutaneous neurogenic inflammation.